A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2002
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263525A1 Method for preparing colloidal particles in the form of nanocapsules
12/11/2002	EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263467A1 Improved paste formulations
12/11/2002	EP1263455A2 Uses of bombesin receptor 3
12/11/2002	EP1263454A2 Methods for enhancing the bioavailability of a drug
12/11/2002	EP1263438A2 Neutral antagonists and use thereof in treating drug abuse
12/11/2002	EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263425A1 Use of comt inhibitors as analgesics
12/11/2002	EP1263424A2 Use of deramciclane for the treatment of anxiety and depression
12/11/2002	EP1263419A2 Compounds capable of binding with the cytoskeleton
12/11/2002	EP1148791B1 Protein material for slow digestion and its use
12/11/2002	EP1077683B1 Antidepressant therapy
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1032572B1 Pyranones, method for the production and use thereof
12/11/2002	EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid
12/11/2002	EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0956009B9 Treatment of neurodegenerative conditions with nimesulide
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0937062B1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
12/11/2002	EP0937060B1 Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002	EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0802985B1 Cell cycle regulated repressor and dna element
12/11/2002	EP0782567B2 Isothiourea derivatives as no synthase inhibitors
12/11/2002	EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
12/11/2002	EP0721455B1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors
12/11/2002	EP0628030B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/11/2002	CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases
12/11/2002	CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist
12/11/2002	CN1384816A Polymorphic forms of sertraline hydrochloride
12/11/2002	CN1384752A Remedies for nervous diseases
12/11/2002	CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions
12/11/2002	CN1384740A Delayed-action form of administration containing tramadol saccharinate
12/11/2002	CN1384739A Oral pharmaceutical forms of administration with a delayed action
12/11/2002	CN1384738A Transdermal drug delivery devices
12/11/2002	CN1384735A Oral dosage forms
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors
12/11/2002	CN1384104A Usage, kit and composition of pyrrole derivative
12/11/2002	CN1384102A Alkyl alcohol piperazine derivative and its application in preparing medicine for treating depression
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1384090A Extraction process of tanshin general phenolic acid and its prepn and use
12/11/2002	CN1383867A Medicine for treating depression and its prepn
12/11/2002	CN1383824A Nasal cavity administrated huperzine prepn
12/11/2002	CN1383818A Application of skullcap stem and leaf general flavone and wild baicalin in preparing dementia resisting medicine
12/11/2002	CN1383753A Health iced tea capable of degrading nicotine and its making process
12/11/2002	CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum
12/10/2002	US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
12/10/2002	US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
12/10/2002	US6492426 Side effect reduction
12/10/2002	US6492425 Inhibitors of transcription factor-NF-κB
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002	US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002	US6492407 Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492388 Such as n-(5-chloro-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-ethoxybenzamide
12/10/2002	US6492387 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
12/10/2002	US6492386 Treating a disease or condition in a mammal, wherein the alpha 7 nicotinic-acetylcholine receptor is implicated
12/10/2002	US6492380 Method of inhibiting neurotrophin-receptor binding
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492378 Substituted isoquinoline derivatives and their use as anticonvulsivants
12/10/2002	US6492374 Benzofuran derivatives, their preparation and use
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492371 Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of Parkinson's Disease
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492349 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
12/10/2002	US6492348 Adenosine derivatives
12/10/2002	US6491948 Increased bioavailability; preventing oxidative destabilization of dnas, rnas and proteins involved in neuronal memory processes;neuroprotective agents possessing preventive properties against memory dysfunctions
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	CA2228752C (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate
12/10/2002	CA2201967C Acetamide derivative having defined particle size
12/10/2002	CA2196085C Mhc complexes and uses thereof
12/10/2002	CA2092431C 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them

1 ... 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 ... 1833